Zhitong Finance App News, Shiyao Group (01093.HK) announced that the phase I/II clinical trial (SYS6088-001) of SYS6088 injection (this product) developed by the Group for the treatment of advanced solid tumors () has been officially launched at the first research center in China.

Zhitong Finance App News, Shiyao Group (01093.HK) announced that the phase I/II clinical trial (SYS6088-001) of SYS6088 injection (this product) developed by the Group for the treatment of advanced solid tumors () has been officially launched at the first research center in China.